BioSpace News Archive

Press Releases

SCYNEXIS Announces One-for-Eight Reverse Stock Split - May 22, 2026

May 25, 2026
·
5 min read
Press Releases

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

May 25, 2026
·
11 min read
Press Releases

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - May 22, 2026

May 25, 2026
·
3 min read
Press Releases

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 22, 2026

May 25, 2026
·
3 min read
Press Releases

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

May 25, 2026
·
2 min read
Press Releases

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

May 25, 2026
·
1 min read
Press Releases

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026

May 25, 2026
·
1 min read
Press Releases

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

May 25, 2026
·
4 min read
Press Releases

LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2026 RESULTS

May 25, 2026
·
12 min read
Press Releases

A single dose of Lilly’s PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia

May 25, 2026
·
8 min read